share_log

ImmunoPrecise Antibodies (CVE:IPA) Issues Earnings Results

ImmunoPrecise Antibodies (CVE:IPA) Issues Earnings Results

免疫精準抗體公司(CVE：IPA)發佈收益業績
kopsource ·  2022/09/17 10:22

ImmunoPrecise Antibodies (CVE:IPA – Get Rating) released its quarterly earnings results on Wednesday. The company reported C($0.38) EPS for the quarter, reports. The firm had revenue of C$4.69 million for the quarter.

免疫精抗體公司(CVE：IPA-GET Rating)週三發佈了季度收益報告。據報道，該公司公佈本季度每股收益為0.38加元。該公司本季度的收入為469萬加元。

ImmunoPrecise Antibodies Stock Performance

免疫精確化抗體庫存表現

IPA stock traded up C$0.37 during mid-day trading on Friday, reaching C$6.87. 14,074 shares of the stock traded hands, compared to its average volume of 20,186. The firm has a market capitalization of C$170.63 million and a PE ratio of -7.72. The business has a 50-day moving average of C$6.32 and a two-hundred day moving average of C$6.19. ImmunoPrecise Antibodies has a 52 week low of C$4.52 and a 52 week high of C$8.99. The company has a quick ratio of 3.60, a current ratio of 4.05 and a debt-to-equity ratio of 3.38.

IPA股價在週五午盤交易中上漲0.37加元，達到6.87加元。該股有14,074股易手，而其平均成交量為20,186股。該公司市值為1.7063億加元，市盈率為-7.72。該業務的50日移動均線切入位在6.32加元，200日移動均線切入位在6.19加元。免疫精抗體的52周低點為4.52加元，52周高位為8.99加元。該公司的速動比率為3.60，流動比率為4.05，債務權益比為3.38。

Get
到達
ImmunoPrecise Antibodies
免疫精確化抗體
alerts:
警報：

About ImmunoPrecise Antibodies

關於免疫精確化抗體

(Get Rating)

(獲取評級)

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
免疫精抗體有限公司及其子公司在美國、加拿大、歐洲、澳大利亞和國際上從事抗體生產和提供相關服務。該公司提供一系列抗體、酶、酶活性分析、關節炎動物產品、蛋白質、去亞胺蛋白、有機生長因子和雜交瘤產品用於研究目的。

Featured Stories

專題報道

  • Stock Market: 3 Islands Of Strength In A Sea Of Red
  • 3 Banks Worth Considering For Q4
  • MarketBeat: Week in Review 9/12 – 9/16
  • No One Told These 3 Stocks It's a Down Week
  • Is There a Cure for What is Ailing Teladoc Stock?
  • 股市：紅海中的三座強國
  • 第四季度值得考慮的3家銀行
  • MarketBeat：回顧一週9/12-9/16
  • 沒有人告訴這三隻股票這是下跌的一週
  • 有什麼辦法可以治癒Teladoc股票的問題嗎？

Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.

每天收到關於免疫精準抗體的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收最新新聞和分析師對免疫精準抗體和相關公司的評級的每日摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論